VBI Vaccines Inc/BC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
VBI Vaccines Inc/BC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2024.
  • VBI Vaccines Inc/BC Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $843K.
  • VBI Vaccines Inc/BC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $22.7M, a 16.7% increase from 2022.
  • VBI Vaccines Inc/BC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $19.4M, a 56.1% decline from 2021.
  • VBI Vaccines Inc/BC annual Net Cash Provided by (Used in) Financing Activities for 2021 was $44.3M, a 63.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $843K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2022 $12K* -$21.6M -99.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $21.6M +$22.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 -$600K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2018 $5K* -$11K -68.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $16K* Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.